Funding Rounds
DeuterOncology

DeuterOncology Series A (2023, $6M)

DeuterOncology

Preclinical-stage biotech company developing cancer treatments.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $6.11M

Investors